The anti-inflammatory AGTR2 and pro-inflammatory, pro-fibrotic AGTR1 gated pathways are deranged in COPD with the ratio of expression favouring the inflammatory profile seen in COVID-19 pneumonia [28–30, 49]. Here, AGTR1 is linked to chronic obstructive pulmonary disease.